New Drug Shows 50% Response Rate in Ovarian Cancer Trial

A groundbreaking treatment is giving hope to women with advanced platinum-resistant ovarian cancer, a diagnosis that has long meant limited options.

In early trials, more than half of patients saw their tumors shrink.